FY2025 · ended Dec 31, 2025 · Revenue $20.92M, +169.4% YoY · Filed Apr 1, 2026
Charlie’s Holdings, Inc. (CHUC) files with the SEC under industry code 2833, Medicinal Chemicals & Botanical Products. In fiscal 2025, which ended Dec 31, 2025, it reported revenue of $20.9 million and net income of $4.5 million. Free cash flow was -$5.8 million. As of Jun 30, 2026 it held $527,000 in cash and investments and $514,000 in total debt.
Revenue (TTM)
$26.18M
+335.7% vs year-ago TTM
Net income (TTM)
$-1.96M
-222.5% vs year-ago TTM
Operating cash flow (TTM)
$-4.20M
+4.1% vs year-ago TTM
Free cash flow
$-5.80M
-640.9% vs prior year
EPS (TTM)
$-0.01
-216.5% vs year-ago TTM
Dividend per share
None
Shares outstanding
274.20M
+6.5% vs prior year
Net cash
$13,000
as of Jun 30, 2026
Operating margin
-9.7%
FY 2026
Company profile
- Industry
- Medicinal Chemicals & Botanical Products (SIC 2833)
- Listed as
- CHUC (OTC)
- Fiscal year ends
- December 31
- Incorporated in
- NV
- Headquarters
- Costa Mesa, CA
- SEC filer status
- Non-accelerated filer, Smaller reporting company
- SEC CIK
- 1134765
- Former names
- True Drinks Holdings, Inc. (until Jul 2, 2019); BAZI INTERNATIONAL, INC. (until Jan 22, 2013); XELR8 HOLDINGS, INC. (until Aug 2, 2010); VITACUBE SYSTEMS HOLDINGS INC (until Mar 9, 2007); INSTANET INC (until Mar 30, 2004)
Other Medicinal Chemicals & Botanical Products companies
- Definium Therapeutics, Inc. DFTX
- Regencell Bioscience Holdings Ltd RGC
- Curaleaf Holdings, Inc. CURLF
- Trulieve Cannabis Corp. TRLV
- Cronos Group Inc. CRON
- TFA Therapeutics, Inc. RAJAF
- Tilray Brands, Inc. TLRY
- SNDL Inc. SNDL
Key figures
Fiscal-year totals from the annual reports. Balance sheet lines are as of each year end.
| Line | FY 2025 Dec 31, 2025 |
FY 2024 Dec 31, 2024 |
FY 2023 Dec 31, 2023 |
FY 2022 Dec 31, 2022 |
FY 2021 Dec 31, 2021 |
|---|---|---|---|---|---|
| Revenue | $20.9M | $7.8M | $16.2M | $26.4M | $21.5M |
| Operating income | -$2.2M | -$3.3M | -$2.2M | -$1.8M | $565,000 |
| Net income | $4.5M | -$4.2M | -$2.1M | -$1.6M | $4.8M |
| Diluted EPS | $0.02 | -$0.02 | -$0.01 | -$0.01 | $0.01 |
| Operating cash flow | -$5.8M | -$1.6M | -$783,000 | -$1.7M | -$1.3M |
| Free cash flow | -$5.8M | — | -$783,000 | -$1.9M | -$1.5M |
| Total assets | $11.6M | $3.9M | $5.8M | $7.1M | $9.2M |
| Total liabilities | $8.1M | $5.7M | $5.9M | $5.4M | $6.1M |
| Stockholders' equity | $3.4M | -$1.8M | -$107,000 | $1.7M | $3.1M |
| Cash and investments | $1.3M | $211,000 | $367,000 | $257,000 | $866,000 |
| Total debt | $636,000 | $2.2M | $2.9M | $2.3M | $912,000 |
Recent SEC filings
| Form | Description | Filed | Period |
|---|---|---|---|
| 10-Q | Quarterly report | Aug 17, 2026 | Jun 30, 2026 |
| 8-K |
Current report
Officer or director change, Regulation FD disclosure
|
Aug 4, 2026 | Aug 3, 2026 |
| 8-K |
Current report
Officer or director change, Shareholder vote results
|
Jun 5, 2026 | Jun 4, 2026 |
| 8-K |
Current report
Material agreement, Unregistered share sale
|
May 21, 2026 | May 20, 2026 |
| 10-Q | Quarterly report | May 20, 2026 | Mar 31, 2026 |
| 10-K | Annual report | Apr 1, 2026 | Dec 31, 2025 |
All 820 Charlie’s Holdings, Inc. SEC filings
Source: SEC EDGAR filings. This is company-reported data, not investment advice.